Clinical Trials in San Diego

Showing 14241-14260 of 14,679 trials

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

NCT00118768

This Phase II study is being conducted in treatment-naive patients (no previous antiviral therapy for Hepatitis C infection) with genotype-1 chronic hepatitis C to evaluate the safety and effectiveness of valopicitabine alone and together with Pegylated Interferon (a drug approved by the Food and Drug Administration for the treatment of Hepatitis C infection).

Chronic Hepatitis C

Merck Sharp & Dohme LLC175 participantsStarted Aug 2005

Phoenix, Arizona, United States • San Diego, California, United States • San Mateo, California, United States +16 more locations

COMPLETEDNA< 1 mile

Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia

NCT00546403

The purpose of this study is to test the effect of modafinil on the negative symptoms, such as blunted affect and social withdrawal, of schizophrenic patients and to determine modafinil's effect on excessive daytime sleepiness. A secondary purpose of the study is to examine the effect of modafinil on cognitive functioning of schizophrenic patients.

Schizophrenia

Veterans Medical Research Foundation26 participantsStarted Feb 2003

San Diego, California, United States

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia

Find Trials by Condition in San Diego

A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Electrophysiologic Measures of Treatment Response in Alzheimer Disease

Antipsychotic Response in Schizophrenia

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

CPG 7909 Injection in Non-Small Cell Lung Cancer

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Hypertension Screening and Treatment Program

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1